Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10,915,750
-
Number of holders
-
255
-
Total 13F shares, excl. options
-
9,997,947
-
Shares change
-
-235,544
-
Total reported value, excl. options
-
$1,963,691,126
-
Value change
-
-$25,626,899
-
Put/Call ratio
-
125%
-
Number of buys
-
115
-
Number of sells
-
-125
-
Price
-
$196.34
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q4 2020
305 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q4 2020.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 255 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,997,947 shares
of 10,915,750 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,728,538 shares), VANGUARD GROUP INC (1,144,114 shares), RENAISSANCE TECHNOLOGIES LLC (1,010,510 shares), DIMENSIONAL FUND ADVISORS LP (425,005 shares), RICE HALL JAMES & ASSOCIATES, LLC (404,428 shares), STATE STREET CORP (347,893 shares), Bank of New York Mellon Corp (216,763 shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (195,785 shares), PRINCIPAL FINANCIAL GROUP INC (195,353 shares), and GEODE CAPITAL MANAGEMENT, LLC (172,877 shares).
This table shows the top 255 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.